ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
IBTA
Ibotta, Inc.
IBTA has the edge over ASTS overall, supported by lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
IBTA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Strong | |
| Strong |
IBTA's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
IBTA PE Valuation
IBTA has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
IBTA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect IBTA's losses to shrink, with revenue growing.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
IBTA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.66 | -121% |
| Q2 2026 | -$0.46 | -113% |
| Q1 2026 | -$0.33 | -115% |
| Q4 2025 | $0.12 | -95% |
| Q3 2025 | $3.19 | +2179% |
| Q2 2025 | $3.65 | +$3.74 |
| Q1 2025 | $2.25 | +29% |
| Q4 2024 | $2.56 | +102% |
IBTA has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over IBTA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
IBTA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $97.8M | +17% |
| Q2 2026 | $88.9M | +3.3% |
| Q1 2026 | $82.5M | -2.5% |
| Q4 2025 | $88.5M | -10% |
| Q3 2025 | $83.3M | -16% |
| Q2 2025 | $86M | -2.2% |
| Q1 2025 | $84.6M | +2.7% |
| Q4 2024 | $98.4M | -1.3% |
IBTA's revenue grew through 2024 and has held roughly level since: $98M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.8% | +2 points |
| Q2 2026 | -2.1% | -3.5 points |
| Q1 2026 | -13% | -9.8 points |
| Q4 2025 | -1.9% | -15 points |
| Q3 2025 | 2.8% | -18 points |
| Q2 2025 | 1.4% | +26 points |
| Q1 2025 | -3.3% | -23 points |
| Q4 2024 | 13% | -13 points |
IBTA has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
IBTA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.5M | +48% |
| Q2 2026 | $12.4M | -44% |
| Q1 2026 | $27.3M | +52% |
| Q4 2025 | $20.3M | -6.8% |
| Q3 2025 | $14.5M | -63% |
| Q2 2025 | $22.2M | -36% |
| Q1 2025 | $18M | -6.5% |
| Q4 2024 | $21.8M | +0.4% |
IBTA has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
IBTA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +68.4K shares |
| 1 year | -21% | -6M shares |
| 3 years | -23% | -6.9M shares |
IBTA has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $13.9M |
| Q2 2026 | $26M |
| Q1 2026 | $44.8M |
| Q4 2025 | $54.8M |
| Q3 2025 | $38M |
| Q2 2025 | $70.4M |
| Q1 2025 | $69.8M |
| Q4 2024 | $15.7M |
IBTA spent $139M buying back its own shares over the past year, down 28% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IBTA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -53.4x | Net Cash |
| Q1 2026 | -1,055.1x | Net Cash |
| Q4 2025 | -25.0x | Net Cash |
| Q3 2025 | -10.4x | Net Cash |
| Q2 2025 | -6.1x | Net Cash |
| Q1 2025 | -16.9x | Net Cash |
| Q4 2024 | -9.7x | Net Cash |
| Q3 2024 | -7.3x | Net Cash |
IBTA has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
IBTA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.6 | Overbought |
| Stochastic | 82.4 | Overbought |
IBTA's weekly RSI is 79 (overbought) and its Stochastic is 82 (overbought).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
IBTA PE vs Technology Sector
| Metric | IBTA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
IBTA has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
IBTA has stronger trend alignment. ASTS is above 1 of 5 weekly averages versus IBTA above 4 of 4.
IBTA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.4 | 20% above |
| 20 week MA | $40.4 | 44% above |
| 50 week MA | $32.7 | 78% above |
| 100 week MA | $37.9 | 53% above |
IBTA is in an uptrend: it's above all four of its weekly moving averages, and 53% above its 100-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
IBTA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $98.0 | $65.8 | -33% |
| 2025 | $65.8 | $22.2 | -66% |
| 2026 YTD | $22.2 | $58.1 | +162% |
IBTA has the edge over ASTS on returns for 2026, with the stronger performance.